Ensysce Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.33
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.16
|
0.00
|
0.16
|
100.00%
|
|
2022-09-30
|
-3.20
|
-5.13
|
-1.93
|
-60.31%
|
|
2022-06-30
|
-3.40
|
-4.80
|
-1.40
|
-41.18%
|
|
2022-03-31
|
-3.20
|
-1.20
|
2.00
|
62.50%
|
|
2021-12-31
|
-0.40
|
-9.00
|
-8.60
|
-2150.00%
|
|
2021-09-30
|
-0.71
|
-0.71
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.06
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
0.25
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-11.13
|
|
2021-12-31
|
-9.52
|
|
2020-12-31
|
0.67
|
|
2019-12-31
|
1.29
|
|
2018-12-31
|
-0.01
|